DKK3 and neoplasm: High-level expression of DKK-3 is associated with chemoresistance and tumor volume progression in HNSCC [56,58], pancreatic [57] and esophageal cancer [10], and with poorer outcomes in HNSCC and esophageal cancer patients [10,70].